BCG vaccine: Worrying proposal for COVID-19
- PMID: 33341305
- PMCID: PMC7745307
- DOI: 10.1016/j.vaccine.2020.12.026
BCG vaccine: Worrying proposal for COVID-19
Abstract
Bacille Calmette-Guérin (BCG) vaccine is proven to be effective in protecting against severe tuberculosis. It has been suggested to be able to exert a non-specific beneficial effect as protection against other infectious diseases. The duration of protection against tuberculosis is estimated to be from 10 to 15 years, but the duration of the protection against other infections is not known, maybe up to 20 years, maybe much shorter than that. We don't know it for sure. BCG induced trained immunity paradigm is based on experimental models, cohort studies with low number of individuals, and some epidemiological data in which other possible interfering factors are not controlled. The titles and scopes of scientific articles should be cautiously considered as they can promote indications of getting vaccinated or revaccinated with BCG, before its effectiveness is confirmed and recommendations are published. Besides, revaccination with BCG can put at serious risk patients with primary or secondary immunodeficiency. Maybe BCG vaccine is effective in preventing COVID-19 deaths or reducing its severity, but may the effect of this vaccine be relevant even with poor health politics and assistance? It is very difficult to compare the epidemiologic data about COVID-19 in different countries. There are countless factors, mainly social and related to the healthcare system, which can be more decisive than the hypothesis of trained immunity induced by BCG. Until now, we can say that BCG's protective role is, at least, insufficient, given many other factors that corroborate SARS-CoV-2 infection and/or its severity.
Keywords: BCG vaccine; COVID-19; Immunity; Innate.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Comment on
-
Stop playing with data: there is no sound evidence that Bacille Calmette-Guérin may avoid SARS-CoV-2 infection (for now).Acta Biomed. 2020 May 11;91(2):207-213. doi: 10.23750/abm.v91i2.9700. Acta Biomed. 2020. PMID: 32420947 Free PMC article. Review.
Similar articles
-
Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.Trials. 2020 Sep 17;21(1):799. doi: 10.1186/s13063-020-04714-3. Trials. 2020. PMID: 32943115 Free PMC article.
-
The influence of vaccination against tuberculosis with the Bacillus-Calmette-Guérin(BCG) vaccine on COVID-19 incidence and mortality - review of the literature.Przegl Epidemiol. 2020;74(2):290-302. doi: 10.32394/pe.74.22. Przegl Epidemiol. 2020. PMID: 33115218 Review.
-
The Potential Roles of BCG Vaccine in the Prevention or Treatment of COVID-19.Front Biosci (Landmark Ed). 2022 May 13;27(5):157. doi: 10.31083/j.fbl2705157. Front Biosci (Landmark Ed). 2022. PMID: 35638424 Review.
-
Research progress on specific and non-specific immune effects of BCG and the possibility of BCG protection against COVID-19.Front Immunol. 2023 Jan 31;14:1118378. doi: 10.3389/fimmu.2023.1118378. eCollection 2023. Front Immunol. 2023. PMID: 36798128 Free PMC article. Review.
-
Tuberculosis vaccine BCG: the magical effect of the old vaccine in the fight against the COVID-19 pandemic.Int Rev Immunol. 2022;41(2):283-296. doi: 10.1080/08830185.2021.1922685. Epub 2021 May 7. Int Rev Immunol. 2022. PMID: 33960271 Free PMC article. Review.
Cited by
-
BCG Vaccination: A potential tool against COVID-19 and COVID-19-like Black Swan incidents.Int Immunopharmacol. 2022 Jul;108:108870. doi: 10.1016/j.intimp.2022.108870. Epub 2022 May 17. Int Immunopharmacol. 2022. PMID: 35597119 Free PMC article. Review.
-
COVID-19 Severity and Neonatal BCG Vaccination among Young Population in Taiwan.Int J Environ Res Public Health. 2021 Apr 18;18(8):4303. doi: 10.3390/ijerph18084303. Int J Environ Res Public Health. 2021. PMID: 33919644 Free PMC article.
-
Implications of the non-specific effect induced by Bacillus Calmette-Guerin (BCG) vaccine on vaccine recommendations.J Pediatr (Rio J). 2023 Mar-Apr;99 Suppl 1(Suppl 1):S22-S27. doi: 10.1016/j.jped.2022.09.002. Epub 2022 Oct 26. J Pediatr (Rio J). 2023. PMID: 36309066 Free PMC article. Review.
References
-
- Tavares Cruz C., Almeida B., Troster E., Oliveira C. Systematic Review of the Non-Specific Effects of Bacillus Calmette-Guérin Vaccine on Child Mortality. J Infectious Diseases Treatment. 2017;03(02):1–8.
-
- Stensballe L.G., Ravn H., Birk N.M., Kjaergaard J., Nissen T.N., Pihl G.T. BCG Vaccination at Birth and Rate of Hospitalization for Infection Until 15 Months of Age in Danish Children: A Randomized Clinical Multicenter Trial. J Pediatric Infect Dis Soc. 2019;8(3):213–220. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous